Joel Greenblatt Ptc Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

$21.9 Billion
Q3 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 18,056 shares of PTCT stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,056

Previous 35,629 49.32%

Holding current value

$1.36 Million

Previous $1.74 Million 36.32%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$43.3 - $62.88 $760,910 - $1.1 Million	-17,573 Reduced 49.32%	18,056 $1.11 Million
Q2 2025 Aug 14, 2025	BUY	$36.19 - $52.13 $1.12 Million - $1.61 Million	30,829 Added 642.27%	35,629 $1.74 Million
Q1 2025 May 15, 2025	BUY	$41.81 - $57.17 $200,688 - $274,416	4,800 New	4,800 $244,000
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $181,777 - $240,487	7,527 New	7,527 $218,000
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $223,654 - $327,177	-5,536 Reduced 44.95%	6,781 $275,000
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $210,337 - $269,316	5,512 Added 81.0%	12,317 $596,000
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $8,382 - $13,697	-250 Reduced 3.54%	6,805 $259,000
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $19,083 - $24,555	456 Added 6.91%	7,055 $354,000
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $168,934 - $298,472	6,599 New	6,599 $264,000
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $177,092 - $214,080	-4,785 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $46 - $68	-1 Reduced 0.02%	4,785 $227,000
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $15,970 - $22,524	-333 Reduced 6.51%	4,786 $292,000
Q2 2020 Aug 13, 2020	SELL	$42.56 - $54.98 $2,170 - $2,803	-51 Reduced 0.99%	5,119 $260,000
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $1,197 - $2,196	37 Added 0.72%	5,170 $231,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $165,385 - $257,009	5,133 New	5,133 $247,000
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $173,598 - $247,256	-5,133 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $181,810 - $230,985	5,133 New	5,133 $231,000
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $311,209 - $437,509	-11,079 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $52,530 - $81,904	-1,761 Reduced 13.71%	11,079 $380,000
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $23,357 - $32,913	689 Added 5.67%	12,840 $603,000
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $312,280 - $581,789	12,151 New	12,151 $410,000
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $299,711 - $413,538	-19,796 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $332,770 - $427,791	19,796	19,796 $396,000

Others Institutions Holding PTCT

# of Institutions

325

Shares Held

83.2M

Call Options Held

811K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account